Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Micromedic Technologies

Novel Microscope Enables Direct Mass Spectrometry Analysis

By BiotechDaily International staff writers
Posted on 07 May 2013
Print article
Image: The iMScope –  Shimadzu’s novel imaging mass microscope (Photo courtesy of Shimadzu).
Image: The iMScope – Shimadzu’s novel imaging mass microscope (Photo courtesy of Shimadzu).
A unique imaging mass microscope has been developed as a new research tool that offers mass spectrometric analysis capability in a single instrument and resolution enabling the visualization of the sub-cellular distribution of molecules.

The positional information of molecules is lost in traditional mass spectrometric analysis. Shimadzu Corporation (Kyoto, Japan) introduces the “iMScope” imaging mass microscope, a new hybrid type of microscope that combines both an optical microscope and an atmospheric pressure ionization mass spectrometer. The optical microscope allows the observation of high-resolution morphological images, and the hybrid ion trap time of flight mass spectrometer allows both identification and visualization of the distribution of specific molecules in the sectioned sample of interest. In addition, the relative abundance of specific molecules (such as drugs and their metabolites) localized in different tissues can be resolved and compared. The dedicated software for the iMScope, “Imaging MS Solution,” can set all operational parameters for viewing optical microscope images, and many sets of operation parameters are available as default method files; hence, users can perform the imaging mass spectrometry without troublesome additional settings.

Proprietary ultrafocusing laser optics and the highly reproducible, high precision 3D automated sample transfer stage result in a superior spatial mass spectrometry resolution of 5 µm—finest spatial resolution in imaging mass spectrometry, using matrix assisted laser desorption ionization (MALDI-TOF) mass spectrometer, commercially available. The iMScope is capable of analyzing living cells or tissue samples by atmosphere MALDI. By superimposing the two images obtained based on these different principles, the team of scientists from Shimadzu, Hamamatsu University of Medicine, and Keio University have created this powerful new research tool.

The iMScope expands potential research opportunities to a diversity of fields, including direct analyses of biological samples as well as of manufactured devices. Potential biological applications include disease biomarker research and functional biology research, such as for development of early stage cancer indicators with biomarkers in cancer tissue; for analysis of micro tissue (smaller than 10 µm; e.g., pigment layer of the retina); as a new pharmacokinetics tool monitoring drug metabolism; and for advancing agricultural and horticultural products via locating the distribution of key compounds. The iMScope is also well suited for various industrial applications, particularly for defect analysis of electronic components and synthetic polymer materials.

In addition to enabling direct analysis of optical microscope samples, the use of atmosphere MALDI, compared to vacuum MALDI, enables analysis of volatile molecules and biological tissues closer living conditions, as well as shorter instrument start-up time. Additionally, the high speed Nd:YAG laser can ionize molecules at 1 kHz, and original ion optics can acquire the ions (which are ionized by several laser shots) and analyze those at once, as this novel technology provides about 100 times faster high-speed imaging mass spectrometry than conventional mass spectrometers. Hence, the ultra-fast performance of the iMScope also accelerates research progress.

The iMScope will be presented at both KSBMB 2013, Korean Society of Biochemistry and Molecular Biology (May 14-16, 2013) and ASMS 2013, American Society of Mass Spectrometry (June 9-13, 2013, in Minneapolis, MN, USA), in conjunction with the new iMLayer, matrix sample preparation device for tissue imaging.

Related Links:
Shimadzu
iMScope


Print article

Channels

Genomics/Proteomics

view channel
Image: Molecular model of E3 ubiquitin ligase (green), E2 ubiquitin enzyme (orange), \"activated ubiquitin\" (cyan), and \"allosteric ubiquitin\" (blue) (Photo courtesy of Dr. Bernhard Lechtenberg, Sanford Burnham Prebys Medical Discovery Institute).

Researchers Resolve Molecular Structure of Critical Ubiquitin-Binding Enzyme

The molecular structure of a protein complex critically involved in diverse cellular functions such as cell signaling, DNA repair, and mounting anti-inflammatory and immune responses has been elucidated... Read more

Drug Discovery

view channel
Image: The “cellXpress” automated imaging analysis software enables to efficiently and accurately detect cellular responses (reflected in green) to nephrotoxic compounds (Photo courtesy of Agency for Science, Technology and Research (Singapore)).

First High-Throughput Imaging Platform for Predicting Kidney Toxicity of Chemicals

Researchers have developed a high-throughput platform of automated cellular imaging that efficiently and accurately predicts renal toxicity of chemical compounds without animal testing, providing an improved... Read more

Business

view channel

Purchase Agreement to Boost Ebola Vaccine Development

A deal to help boost development of a vaccine to protect against Ebolavirus infection was finalized at the recent Davos Conference in Switzerland. Gavi (Geneva, Switzerland), the global alliance for vaccines and immunizations, announced that it would spend five million USD to purchase the Ebola vaccine under development... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.